Ioversol
Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media
Sold as OPTIRAY 320 · OPTIRAY 350 · OPTIRAY 300 · OPTIRAY 320 (ULTRAJECT) · OPTIRAY 350 (ULTRAJECT)
- Drug class
- Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media
- Availability
- See label
- Routes
- Intravascular
- Markets covered
- 2
- Products on record
- 4
Overview
Ioversol is an active pharmaceutical ingredient in the Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media group (V08AB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 3 | October 10, 2025 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
GBUnited Kingdom· MHRA
3 products
Uses
This medicinal product is for diagnostic use only. Optiray 350 is a non-ionic X-ray contrast medium, which is indicated in adults for angiography throughout the cardiovascular system including coronary, peripheral, visceral and renal angiography, aortography and left ventriculography.
Optiray 350 is also indicated in adults for use in computed tomography of the head and body, intravenous urography, venography and intravenous and intraarterial digital subtraction angiography (IA-DSA and IV- DSA).
How to take
CACanada· Health Canada
1 product
Uses
52 Page 3 of 55 OPTIRAY® Ioversol Injection PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Clinically Relevant Non-medicinal Ingredients Intravascular injection or subarachnoidal Solution for injection, 240 mgI/mL, 300 mgI/mL, 320 mgI/mL, and 350 mgI/mL Edetate Calcium Disodium USP, Hydrochloric Acid NF, Sodium Hydroxide NF, Tromethamine HCl, Tromethamine USP.
For a complete listing see Dosage Forms, Composition and Packaging section. INDICATIONS AND CLINICAL USE Adults Optiray 350 administered intravascularly is recommended in adults for coronary arteriography and ventriculography, peripheral and visceral arteriography, intravenous contrast enhancement in computed tomography of the head and body, excretory urography, intravenous digital subtraction angiography and venography.
Optiray 320 administered intravascularly is recommended for angiography throughout the cardiovascular system in adults. The uses include cerebral, coronary, peripheral, visceral and renal arteriography, aortography and left ventriculography.
Drug interactions
Known interactions involving Ioversol. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL123080032 · revised October 10, 2025
- [2]Health Canada (DPD) · 02387441 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.